Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 8828

BillFederalHouseIn Committee
To address potential conflicts of interest among entities serving as Food and Drug Administration contractors, and for other purposes.
About This Bill
Committee
Congress
117th (2021–2023)
Introduced
September 14, 2022
Cosponsors (0)
None
View PDF ↗

Summary

Highlight any text to annotate
FDA Ethics Act of 2022 This bill establishes several requirements for entities that contract with the Food and Drug Administration (FDA) relating to conflicts of interest, including requiring contractors to disclose conflicts of interest on an ongoing basis and prohibiting the FDA from hiring consultants who simultaneously provide services to drug manufacturers or other entities that are regulated by the FDA.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.